Impact of HSV-1 Infection on Alzheimer's Disease Neurodegeneration Markers: Insights from LUHMES 2D and 3D Neuronal Models
Preprint
- 5 November 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Herpes simplex virus type 1 (HSV-1) has been proposed as an environmental risk factor for Alzheimer’s disease (AD). Viral infection of neuronal cells can reproduce hallmark pathological features of AD, including intracellular beta-amyloid (Aβ) accumulation, tau hyperphosphorylation, and lysosomal dysfunction. However, the molecular mechanisms underlying these alterations remain unclear, partly due to limitations of existing experimental models. Here, we established both two-dimensional (2D) and three-dimensional (3D) LUHMES neuronal cultures—a human mesencephalic-derived neural cell line that differentiates rapidly into mature neurons—to investigate HSV-1-induced neurodegeneration. Our results demonstrate that HSV-1 infection induces key features of AD, including intracellular accumulation of Aβ peptides and hyperphosphorylation of tau protein. Moreover, we observed significant disruptions in the autophagy-lysosome pathway, characterized by increased LC3-II levels, reduced cathepsin activity, and impaired lysosomal burden. Notably, these AD-like alterations were reproduced in 3D LUHMES neuronal aggregates, confirming their susceptibility to productive HSV-1 infection. Collectively, these findings indicate that HSV-1 not only triggers classical AD-like neuropathological markers but also disrupts cellular clearance mechanisms that may contribute to neuronal dysfunction and degeneration. This study validates the 3D LUHMES system as a physiologically relevant human neuronal model to study virus-induced neurodegeneration and its mechanistic links to AD pathology.Keywords
All Related Versions
This publication has 48 references indexed in Scilit:
- Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic ImplicationsMolecular Neurobiology, 2024
- An overview on the impact of viral pathogens on Alzheimer's diseaseAgeing Research Reviews, 2024
- Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in TaiwanNeurotherapeutics, 2018
- 3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic EffectsCurrent Protocols in Toxicology, 2017
- A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysisArchives of Toxicology, 2015
- Herpes simplex virus type I induces the accumulation of intracellular β-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cellsNeurobiology of Aging, 2012
- Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cellsJournal of Neuroscience Research, 2012
- Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaquesThe Journal of Pathology, 2008
- Latent herpes simplex virus type 1 in normal and Alzheimer's disease brainsJournal of Medical Virology, 1991
- Production and titration of African swine fever virus in porcine alveolar macrophagesJournal of Virological Methods, 1982